Cargando…
Assessment of metamorphopsia in patients with central serous chorioretinopathy
BACKGROUND: To evaluate the presence and extent of metamorphopsia using M-CHARTS™ (Inami Co., Tokyo, Japan) in patients with central serous chorioretinopathy (CSC). DESIGN: Retrospective consecutive medical record review in a university hospital. MATERIALS AND METHODS: We examined 33 eyes of 33 cons...
Autores principales: | Bae, Sin Woo, Chae, Ju Byung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714955/ https://www.ncbi.nlm.nih.gov/pubmed/23685489 http://dx.doi.org/10.4103/0301-4738.112162 |
Ejemplares similares
-
Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study
por: Bae, Seokhyun, et al.
Publicado: (2015) -
Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity
por: Hayashida, Mayuka, et al.
Publicado: (2020) -
The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021) -
Central Serous Chorioretinopathy Classification
por: Vilela, Manuel, et al.
Publicado: (2020) -
Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)